Activist investor Starboard Value has taken a sizeable stake in Kenvue, the maker of Tylenol and Listerine, and is seeking ...

Activist investor Starboard Value reportedly has taken a large stake in consumer health products maker Kenvue.

The liver is known for its ability to regenerate. It can completely regrow itself even after two-thirds of its mass has been ...

Starboard Value, an activist investor, has reportedly acquired a substantial stake in Kenvue Inc, the company behind popular ...

Starboard wants Kenvue, which was spun out of Johnson & Johnson last year and has a market value of over $40 billion, to make ...

While tech-based growth stocks might seem like the right play, you can't ignore dividends if you want to have a strong ...

Shares of consumer-products company Kenvue Inc.rose the most in more than two months after activist investor Starboard Value took a stake in the Tylenol maker with an eye toward making changes to ...

Starboard founder and CEO Jeff Smith is expected to discuss the hedge fund's plans for Kenvue at an investor conference tomorrow. Shares of Kenvue (KVUE) took off Monday morning on indications ...

Activist investor Starboard Value has taken a sizeable stake in Kenvue Inc., the maker of Tylenol and Listerine, and is seeking changes, according to reports Sunday night. The Wall Street Journal ...

Kenvue is guiding for $1.10 to $1.20 in 2024 earnings per share and 2% to 4% organic sales growth. If it achieves the ...

Activist investor Starboard Value reportedly has taken a large stake in consumer health care products maker Kenvue. Starboard founder and CEO Jeff Smith is expected to discuss the hedge fund's ...